Hemic & Lymphatic

DC 7725

Myelodysplastic syndromes

Educational use only. Not legal or medical advice. Read 38 CFR §4.117 on eCFR
Diagnostic Code
7725
CFR Section
§4.117 — Hemic & Lymphatic

Rating Tiers

100%

Requiring peripheral blood or bone marrow stem cell transplant; or requiring chemotherapy

60%

Requiring 4 or more blood or platelet transfusions per 12-month period; or infections requiring hospitalization 3 or more times per 12-month period

30%

Requiring at least 1 but no more than 3 blood or platelet transfusions per 12-month period; infections requiring hospitalization at least 1 but no more than 2 times per 12-month period; or requiring biologic therapy on an ongoing basis or erythropoiesis stimulating agent (ESA) for 12 weeks or less per 12-month period

What Raters Look For

Based on M21-1 adjudication criteria for Hemic & Lymphatic conditions. These are the factors a VA rater evaluates when assigning a rating percentage.

M21-1 III.iv.4.G
  • •Complete blood count (CBC) values: hemoglobin, platelet count, white cell count
  • •Whether transfusions are required and how frequently
  • •Bone marrow biopsy or transplant history
  • •Response to treatment and current treatment regimen
  • •Constitutional symptoms: fatigue, weight loss, fever